Objective Capital Partners Retained by Marina Biotech to Explore Strategic Alternatives

Posted February 19, 2016 by OCP | Post a Comment

Bothell, WA - February 18, 2016 - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its Board of Directors has authorized a process to explore a range of strategic alternatives to enhance shareholder value. The Company has retained Objective Capital Partners, LLC as its exclusive advisor to assist the company in exploring such alternatives. These alternatives will focus on building upon the Company's strong foundation and could include selling, partnering or raising capital to continue growth and development in the business.

(more…)

Healthcare, Life Sciences, Press News, Technology, Strategic Advisory

Objective Capital Partners Retained by AVACEN Medical Inc. to Explore Strategic Alternatives

Posted February 11, 2016 by OCP | Post a Comment

San Diego, CA – February 2, 2016 – AVACEN Medical, a privately held medical device company, announced that its Board of Directors has authorized a process to explore a range of strategic alternatives to enhance shareholder value. The Company has retained Objective Capital Partners, LLC as its exclusive advisor to assist the company in exploring such alternatives. These alternatives, all of which are focused on building upon the Company’s strong foundation, could include selling, partnering or raising capital to continue growth and development in the business.

(more…)

Healthcare, Life Sciences, Press News, Strategic Advisory

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com